Annual Total Assets
$229.43 M
+$35.13 M+18.08%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual total assets is currently $229.43 million, with the most recent change of +$35.13 million (+18.08%) on 31 December 2023. During the last 3 years, it has risen by +$25.64 million (+12.58%). LXRX annual total assets is now -64.81% below its all-time high of $651.96 million, reached on 31 December 2015.LXRX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$321.12 M
-$52.23 M-13.99%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly total assets is currently $321.12 million, with the most recent change of -$52.23 million (-13.99%) on 30 September 2024. Over the past year, it has increased by +$44.64 million (+16.15%). LXRX quarterly total assets is now -50.74% below its all-time high of $651.96 million, reached on 31 December 2015.LXRX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.1% | +16.1% |
| 3 y3 years | +12.6% | +86.3% |
| 5 y5 years | -19.3% | -27.8% |
LXRX Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +67.6% | -23.0% | +185.9% |
| 5 y | 5 years | -45.1% | +67.6% | -27.8% | +185.9% |
| alltime | all time | -64.8% | +929.1% | -50.7% | +1435.0% |
Lexicon Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $321.12 M(-14.0%) |
| June 2024 | - | $373.36 M(-10.5%) |
| Mar 2024 | - | $417.22 M(+81.9%) |
| Dec 2023 | $229.43 M(+18.1%) | $229.43 M(-17.0%) |
| Sept 2023 | - | $276.48 M(-12.7%) |
| June 2023 | - | $316.72 M(+94.6%) |
| Mar 2023 | - | $162.72 M(-16.3%) |
| Dec 2022 | $194.30 M(+41.9%) | $194.30 M(+1.4%) |
| Sept 2022 | - | $191.69 M(+70.7%) |
| June 2022 | - | $112.33 M(-17.5%) |
| Mar 2022 | - | $136.18 M(-0.5%) |
| Dec 2021 | $136.91 M(-32.8%) | $136.91 M(-20.6%) |
| Sept 2021 | - | $172.33 M(+0.4%) |
| June 2021 | - | $171.67 M(-11.2%) |
| Mar 2021 | - | $193.26 M(-5.2%) |
| Dec 2020 | $203.79 M(-51.2%) | $203.79 M(+13.9%) |
| Sept 2020 | - | $178.93 M(-44.5%) |
| June 2020 | - | $322.54 M(-13.0%) |
| Mar 2020 | - | $370.57 M(-11.3%) |
| Dec 2019 | $417.71 M(+47.0%) | $417.71 M(-6.0%) |
| Sept 2019 | - | $444.59 M(+90.7%) |
| June 2019 | - | $233.14 M(-9.8%) |
| Mar 2019 | - | $258.52 M(-9.0%) |
| Dec 2018 | $284.14 M(-34.9%) | $284.14 M(-8.4%) |
| Sept 2018 | - | $310.19 M(-6.8%) |
| June 2018 | - | $332.94 M(-13.9%) |
| Mar 2018 | - | $386.81 M(-11.4%) |
| Dec 2017 | $436.54 M(-8.2%) | $436.54 M(+32.5%) |
| Sept 2017 | - | $329.49 M(-9.4%) |
| June 2017 | - | $363.51 M(-8.3%) |
| Mar 2017 | - | $396.26 M(-16.7%) |
| Dec 2016 | $475.63 M(-27.0%) | $475.63 M(-8.0%) |
| Sept 2016 | - | $516.95 M(-7.4%) |
| June 2016 | - | $558.13 M(-8.7%) |
| Mar 2016 | - | $611.34 M(-6.2%) |
| Dec 2015 | $651.96 M(+38.3%) | $651.96 M(+66.7%) |
| Sept 2015 | - | $391.14 M(-6.0%) |
| June 2015 | - | $415.96 M(-6.5%) |
| Mar 2015 | - | $444.68 M(-5.7%) |
| Dec 2014 | $471.38 M(+71.9%) | $471.38 M(+151.4%) |
| Sept 2014 | - | $187.52 M(-16.3%) |
| June 2014 | - | $224.06 M(-8.0%) |
| Mar 2014 | - | $243.60 M(-11.1%) |
| Dec 2013 | $274.16 M(-26.3%) | $274.16 M(-8.4%) |
| Sept 2013 | - | $299.46 M(-7.4%) |
| June 2013 | - | $323.39 M(-6.9%) |
| Mar 2013 | - | $347.27 M(-6.6%) |
| Dec 2012 | $371.78 M | $371.78 M(+3.9%) |
| Sept 2012 | - | $357.83 M(-6.1%) |
| June 2012 | - | $381.06 M(-5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $402.79 M(-6.4%) |
| Dec 2011 | $430.51 M(+17.3%) | $430.51 M(+46.1%) |
| Sept 2011 | - | $294.71 M(-6.7%) |
| June 2011 | - | $315.92 M(-8.0%) |
| Mar 2011 | - | $343.41 M(-6.4%) |
| Dec 2010 | $366.88 M(+42.3%) | $366.88 M(-1.1%) |
| Sept 2010 | - | $370.87 M(+1.6%) |
| June 2010 | - | $365.15 M(-10.8%) |
| Mar 2010 | - | $409.21 M(+58.8%) |
| Dec 2009 | $257.76 M(-1.4%) | $257.76 M(+15.2%) |
| Sept 2009 | - | $223.68 M(-8.5%) |
| June 2009 | - | $244.33 M(-0.0%) |
| Mar 2009 | - | $244.45 M(-6.5%) |
| Dec 2008 | $261.51 M(-29.2%) | $261.51 M(-7.8%) |
| Sept 2008 | - | $283.70 M(-8.6%) |
| June 2008 | - | $310.31 M(-7.8%) |
| Mar 2008 | - | $336.57 M(-8.9%) |
| Dec 2007 | $369.30 M(+94.1%) | $369.30 M(-2.4%) |
| Sept 2007 | - | $378.19 M(+88.2%) |
| June 2007 | - | $200.96 M(+20.1%) |
| Mar 2007 | - | $167.37 M(-12.0%) |
| Dec 2006 | $190.27 M(-13.0%) | $190.27 M(+15.1%) |
| Sept 2006 | - | $165.35 M(-9.5%) |
| June 2006 | - | $182.67 M(-10.1%) |
| Mar 2006 | - | $203.30 M(-7.0%) |
| Dec 2005 | $218.71 M(+3.2%) | $218.71 M(+4.7%) |
| Sept 2005 | - | $208.97 M(+8.8%) |
| June 2005 | - | $192.15 M(+1.7%) |
| Mar 2005 | - | $188.91 M(-10.9%) |
| Dec 2004 | $211.98 M(-25.4%) | $211.98 M(-1.5%) |
| Sept 2004 | - | $215.13 M(-2.7%) |
| June 2004 | - | $221.18 M(-15.9%) |
| Mar 2004 | - | $262.94 M(-7.5%) |
| Dec 2003 | $284.20 M(+40.9%) | $284.20 M(+35.7%) |
| Sept 2003 | - | $209.39 M(+20.8%) |
| June 2003 | - | $173.39 M(-4.7%) |
| Mar 2003 | - | $181.97 M(-9.8%) |
| Dec 2002 | $201.77 M(-15.9%) | $201.77 M(+1.4%) |
| Sept 2002 | - | $198.89 M(-7.0%) |
| June 2002 | - | $213.84 M(-5.6%) |
| Mar 2002 | - | $226.52 M(-5.6%) |
| Dec 2001 | $239.99 M(+8.7%) | $239.99 M(-3.9%) |
| Sept 2001 | - | $249.68 M(+12.5%) |
| June 2001 | - | $222.00 M(+3.3%) |
| Mar 2001 | - | $214.89 M(-2.6%) |
| Dec 2000 | $220.69 M(+889.9%) | $220.69 M(-0.2%) |
| Sept 2000 | - | $221.11 M(-0.4%) |
| June 2000 | - | $222.04 M(+961.4%) |
| Mar 2000 | - | $20.92 M |
| Dec 1999 | $22.30 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual total assets year-on-year change?
- What is Lexicon Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly total assets year-on-year change?
What is Lexicon Pharmaceuticals annual total assets?
The current annual total assets of LXRX is $229.43 M
What is the all time high annual total assets for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual total assets is $651.96 M
What is Lexicon Pharmaceuticals annual total assets year-on-year change?
Over the past year, LXRX annual total assets has changed by +$35.13 M (+18.08%)
What is Lexicon Pharmaceuticals quarterly total assets?
The current quarterly total assets of LXRX is $321.12 M
What is the all time high quarterly total assets for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly total assets is $651.96 M
What is Lexicon Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, LXRX quarterly total assets has changed by +$44.64 M (+16.15%)